Oncolys BioPharma Email Formats
Biotechnology Research • 
Minato-Ku, Tokyo, Japan • 21-50 Employees
Oncolys BioPharma Email Formats
Oncolys BioPharma uses 2 email formats. The most common is {last name} (e.g., doe@oncolys.com), used 73.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@oncolys.com | 73.7% |
{first name}.{last name} | john.doe@oncolys.com | 26.3% |
Key Contacts at Oncolys BioPharma
Makoto Yokoyama
Director Cmc Planning
Hisao Furitsu
Senior Director, Cmc Planning
Toru Saito
Non Executive Director
Keisuke Terashima
Director, Business Development
Toshiaki Sakaguchi
Senior Director Quality Assurance Division
Hitoshi Kawamura
Director
圭司 吉村
Director
Company overview
| Headquarters | 4-1-28, Minato-ku, Tokyo 105-0001, JP |
| Phone number | +81354721578 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Oncology, Orphan Drugs, Emerging Infectious Diseases, Oncolytic Viral Therapy |
| Founded | 2004 |
| Employees | 21-50 |
| Socials |
About Oncolys BioPharma
Oncolys BioPharma Inc. is a Tokyo-based bioventure established in Japan in March 2004. Its mission is to contribute to the advancement of medical science in the world through bringing innovation to the existing treatments for cancer and serious infectious diseases, using its virology-based new drug discovery technologies. The company operates in two business segments. Pharmaceutical Business segment is engaged in the research, development, manufacture and marketing of novel drugs. Its major pipeline Telomelysin (OBP-301), an oncolytic adenovirus immunotherapy is in clinical development targeting various types of solid tumors including melanoma , HCC and esophageal cancer. Along with Telomelysin, an anti-HIV drug OBP-601 (Censavudine) and a novel HDAC inhibitor OBP-801 are also under development in the United States. Diagnostics Business segment is engaged in the research, development, manufacture and marketing of CTC (Circulating Tumor Cell) detection adenovirus TelomeScan, as well as the provision of inspection services. Oncolys was listed on the Tokyo Stock Exchange Mothers Market in December 2014 and has a clinical laboratory center in Kobe, Japan and a subsidiary in New Jersey, USA.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Oncolys BioPharma has 10 employees across 5 departments.
Departments
Number of employees
Funding Data
Oncolys BioPharma has never raised funding before.
Oncolys BioPharma Tech Stack
Discover the technologies and tools that power Oncolys BioPharma's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CDN
Web servers
CDN
JavaScript libraries
Tag managers
JavaScript libraries
Font scripts
UI frameworks
Video players
Analytics
UI frameworks
United States
United Kingdom
France
Saudi Arabia
South Africa
Frequently asked questions
4.8
40,000 users
